Bakkenolides and Caffeoylquinic Acids from the Aerial Portion of Petasites japonicus and Their Bacterial Neuraminidase Inhibition Ability

Bibliographic Details
Title: Bakkenolides and Caffeoylquinic Acids from the Aerial Portion of Petasites japonicus and Their Bacterial Neuraminidase Inhibition Ability
Authors: Hyun Sim Woo, Kyung-Chul Shin, Jeong Yoon Kim, Yeong-Su Kim, Young Jun Ban, Yu Jin Oh, Hae Jin Cho, Deok-Kun Oh, Dae Wook Kim
Source: Biomolecules, Vol 10, Iss 6, p 888 (2020)
Publisher Information: MDPI AG, 2020.
Publication Year: 2020
Collection: LCC:Microbiology
Subject Terms: bacterial neuraminidase inhibitors, bakkenolides, caffeoylquinic acid, Petasites japonicus plant extract, competitive inhibition, non-competitive inhibition, Microbiology, QR1-502
More Details: Petasites japonicus have been used since a long time in folk medicine to treat diseases including plague, pestilential fever, allergy, and inflammation in East Asia and European countries. Bioactive compounds that may prevent and treat infectious diseases are identified based on their ability to inhibit bacterial neuraminidase (NA). We aimed to isolate and identify bioactive compounds from leaves and stems of P. japonicas (PJA) and elucidate their mechanisms of NA inhibition. Key bioactive compounds of PJA responsible for NA inhibition were isolated using column chromatography, their chemical structures revealed using 1 H NMR, 13 C NMR, DEPT, and HMBC, and identified to be bakkenolide B (1), bakkenolide D (2), 1,5-di-O-caffeoylquinic acid (3), and 5-O-caffeoylquinic acid (4). Of these, 3 exhibited the most potent NA inhibitory activity (IC50 = 2.3 ± 0.4 μM). Enzyme kinetic studies revealed that 3 and 4 were competitive inhibitors, whereas 2 exhibited non-competitive inhibition. Furthermore, a molecular docking simulation revealed the binding affinity of these compounds to NA and their mechanism of inhibition. Negative-binding energies indicated high proximity of these compounds to the active site and allosteric sites of NA. Therefore, PJA has the potential to be further developed as an antibacterial agent for use against diseases associated with NA.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2218-273X
Relation: https://www.mdpi.com/2218-273X/10/6/888; https://doaj.org/toc/2218-273X
DOI: 10.3390/biom10060888
Access URL: https://doaj.org/article/0ffe5b8709584a0eb46fc56e0d258775
Accession Number: edsdoj.0ffe5b8709584a0eb46fc56e0d258775
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:2218273X
DOI:10.3390/biom10060888
Published in:Biomolecules
Language:English